Recent research consolidates three critical findings about L-arginine that reshape clinical understanding of this amino acid’s neurological potential. First, the supplement enhances cerebral blood flow through mechanisms distinct from its cardiovascular effects, offering a dual-system benefit for aging brains. Second, the arginine paradox reveals why supplementation remains effective despite adequate baseline levels—local tissue availability and cellular signaling pathways, rather than systemic deficiency, appear to mediate the response.
Third, emerging preclinical evidence suggests L-arginine may influence how amyloid-β proteins aggregate in neural tissue, though human evidence in this domain remains limited. Clinicians should note that while cerebral blood flow and cognitive improvements are established in human studies, protein-level effects require further investigation before clinical recommendations can be made.
For patients and practitioners, these findings support L-arginine’s consideration in comprehensive brain health strategies, particularly for older adults concerned with cognitive aging and cerebrovascular function.
Was this article helpful?
